c-MYC mRNA destabilization inhibited lethal pancreatic cancer in vivo with significant survival outcomes
Sign Up to like & getrecommendations! Published in 2025 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2025.1630476
Abstract: Pancreatic ductal carcinoma is the most common and deadly form of pancreatic cancer, with an 11% survival rate. There is currently no cure. The first-line, mainstay therapy for pancreatic cancer is gemcitabine, capecitabine, or FOLFIRINOX.… read more here.
Keywords: cancer; lethal pancreatic; vivo; significant survival ... See more keywords